{"DataElement":{"publicId":"6610535","version":"1","preferredName":"Autoimmune Disease or Disorder Present Code","preferredDefinition":"Text code to represent the presence of disease related to autoimmune disorders.","longName":"AUTO_DZ_DIS_PRST_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6610527","version":"1","preferredName":"Autoimmune Disease or Disorder Present","preferredDefinition":"Pertaining to autoimmunity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Being or existing in a specified place or at the specified time.","longName":"4156015v1.0:2233878v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"4156015","version":"1","preferredName":"Autoimmune Disease or Disorder","preferredDefinition":"Pertaining to autoimmunity.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C37916:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune","conceptCode":"C37916","definition":"Pertaining to autoimmunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F250136F-E8EA-44FD-E040-BB89AD436D96","latestVersionIndicator":"Yes","beginDate":"2014-02-13","endDate":null,"createdBy":"LEVENTHM","dateCreated":"2014-02-13","modifiedBy":"ONEDATA","dateModified":"2014-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F729E99-7C69-4FF0-E053-F662850A54A1","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"SOKKERL","dateModified":"2019-02-26","changeDescription":"1/15/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6610529","version":"1","preferredName":"Disease or Disorder Code","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6610529v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"RA","valueDescription":"Rheumatoid Arthritis","ValueMeaning":{"publicId":"2570667","version":"1","preferredName":"Rheumatoid Arthritis","longName":"2570667","preferredDefinition":"A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatoid Arthritis","conceptCode":"C2884","definition":"A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E118-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CZECHS","dateModified":"2008-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F8183FF-B25F-52B2-E053-F662850ABA75","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"UC","valueDescription":"Ulcerative Colitis","ValueMeaning":{"publicId":"4264977","version":"1","preferredName":"Ulcerative Colitis","longName":"4264977","preferredDefinition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulcerative Colitis","conceptCode":"C2952","definition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3D16-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BE6F-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"MS","valueDescription":"Multiple Sclerosis","ValueMeaning":{"publicId":"2760060","version":"1","preferredName":"Multiple Sclerosis","longName":"2760060","preferredDefinition":"A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis","conceptCode":"C3243","definition":"A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FE4369C-D09F-4E65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BE85-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"NS","valueDescription":"Other Autoimmune Disease","ValueMeaning":{"publicId":"3059907","version":"1","preferredName":"Other Autoimmune Disease","longName":"3059907","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"842374FF-4E3F-D4FB-E040-BB89AD435BC2","latestVersionIndicator":"Yes","beginDate":"2010-04-13","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BE9C-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"SJS","valueDescription":"Sjogrens Syndrome (SjS)","ValueMeaning":{"publicId":"6610534","version":"1","preferredName":"Sjogrens Syndrome (SjS)","longName":"6610534","preferredDefinition":"Sjogrens Syndrome (SjS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F81E574-BEA7-785A-E053-F662850AB761","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BEC0-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"SLE","valueDescription":"Systemic Lupus Erythematosus","ValueMeaning":{"publicId":"2593562","version":"1","preferredName":"Systemic Lupus Erythematosus","longName":"2593562","preferredDefinition":"A chronic inflammatory connective tissue disease marked by skin rashes, joint pain and swelling, inflammation of the kidneys, inflammation of the fibrous tissue surrounding the heart (i.e., the pericardium), as well as other problems.  Not all affected individuals display all of these problems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Lupus Erythematosus","conceptCode":"C3201","definition":"An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BED21B-19CD-6CE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BED6-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"DM","valueDescription":"Dermatomyositis","ValueMeaning":{"publicId":"2593566","version":"1","preferredName":"Dermatomyositis","longName":"2593566","preferredDefinition":"A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatomyositis","conceptCode":"C26744","definition":"Inflammation of the skin and muscle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BED315-43F8-6D1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F81E574-BEEC-785A-E053-F662850AB761","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","deletedIndicator":"No"},{"value":"SSC","valueDescription":"Systemic Sclerosis (SSC)","ValueMeaning":{"publicId":"6650858","version":"1","preferredName":"Systemic Sclerosis (SSC)","longName":"6650858","preferredDefinition":"A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, Raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Scleroderma","conceptCode":"C72070","definition":"A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, Raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82473C0D-C3B2-1361-E053-F662850A0559","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"SOKKERL","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82473C0D-C3CB-1361-E053-F662850A0559","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"ONEDATA","dateModified":"2019-02-19","deletedIndicator":"No"},{"value":"CD","valueDescription":"Crohn's Disease (CD)","ValueMeaning":{"publicId":"6650859","version":"1","preferredName":"Crohn's Disease (CD)","longName":"6650859","preferredDefinition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crohn Disease","conceptCode":"C2965","definition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82473C0D-C3D5-1361-E053-F662850A0559","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82473C0D-C3EE-1361-E053-F662850A0559","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"ONEDATA","dateModified":"2019-02-19","deletedIndicator":"No"},{"value":"PsOPsA","valueDescription":null,"ValueMeaning":{"publicId":"11041894","version":"1","preferredName":"Psoriasis (PSO) And Psoriatic Arthritis","longName":"11041894v1.00","preferredDefinition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Joint inflammation associated with psoriasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psoriasis","conceptCode":"C3346","definition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Psoriatic Arthritis","conceptCode":"C61277","definition":"Joint inflammation associated with psoriasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E36EB6-1FF9-5D6F-E053-731AD00A503A","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5E36EB6-1FFA-5D6F-E053-731AD00A503A","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2736358","version":"1","preferredName":"Disease or Disorder Code","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A system of numbered categories for representation of data.","longName":"C2991:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48DD0467-E719-51E8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-20","modifiedBy":"ONEDATA","dateModified":"2008-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F8183FF-B23B-52B2-E053-F662850ABA75","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","changeDescription":"1/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Autoimmune disorder","type":"Preferred Question Text","description":"Autoimmune disorder","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F81F502-8A42-04D3-E053-F662850A8BB4","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"SOKKERL","dateModified":"2019-02-26","changeDescription":"1/15/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}